日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Modified high-dose melphalan and autologous SCT for AL amyloidosis or high-risk myeloma: analysis of SWOG trial S0115

改良高剂量美法仑联合自体干细胞移植治疗AL淀粉样变性或高危骨髓瘤:SWOG试验S0115分析

Sanchorawala, V; Hoering, A; Seldin, D C; Finn, K T; Fennessey, S A; Sexton, R; Mattar, B; Safah, H F; Holmberg, L A; Dean, R M; Orlowski, R Z; Barlogie, B

Preclinical development of siRNA therapeutics for AL amyloidosis.

针对AL淀粉样变性的siRNA疗法的临床前开发

Hovey B M, Ward J E, Soo Hoo P, O'Hara C J, Connors L H, Seldin D C

Febrile reactions occurring with second cycle of high-dose melphalan and SCT in patients with AL amyloidosis: a 'melphalan recall' reaction

AL淀粉样变性患者在接受第二个疗程的高剂量美法仑和干细胞移植后出现发热反应:一种“美法仑召回”反应

Rosenzweig, M; Seldin, D C; Remick, D G; Skinner, M; Quillen, K; Oran, B; Finn, K T; Sanchorawala, V

Murine c-mpl: a member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal

小鼠 c-mpl:造血生长因子受体超家族成员,可传递增殖信号

Skoda, R C; Seldin, D C; Chiang, M K; Peichel, C L; Vogt, T F; Leder, P

Homology of the rat basophilic leukemia cell and the rat mucosal mast cell

大鼠嗜碱性白血病细胞与大鼠黏膜肥大细胞的同源性

Seldin, D C; Adelman, S; Austen, K F; Stevens, R L; Hein, A; Caulfield, J P; Woodbury, R G